Fosbretabulin
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Fosbretabulin, covering 2011-11-01 to 2017-10-19. Get the full timeline:
Most recent: Clinical Trial Update: A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers [Phase 2]